APA (7th ed.) Citation

Harrison, C. N., Heidel, F. H., Vannucchi, A. M., Kiladjian, J., Hayat, A., Passamonti, F., . . . Ribrag, V. (2022). A phase Ib dose-finding study of panobinostat and ruxolitinib in myelofibrosis. HemaSphere, 6(8), . https://doi.org/10.1097/HS9.0000000000000757

Chicago Style (17th ed.) Citation

Harrison, Claire N., et al. "A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis." HemaSphere 6, no. 8 (2022). https://doi.org/10.1097/HS9.0000000000000757.

MLA (9th ed.) Citation

Harrison, Claire N., et al. "A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis." HemaSphere, vol. 6, no. 8, 2022, https://doi.org/10.1097/HS9.0000000000000757.